NCT00229203 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Plitidepsin 5 mg/m2 given as a 3-hour i.v. infusion every two weeks.
- id
- FG000
- title
- Plitidepsin
- description
- Plitidepsin 5 mg/m2 given as a 3-hour i.v. infusion every two weeks plus 20 mg of oral dexamethasone every day on days 1 to 4 of each cycle, starting at the same time than the plitidepsin infusion.
- id
- FG001
- title
- Plitidepsin + Dexamethasone
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 18
- group Id
- FG001
- num Subjects
- 9
- type
- Progressive disease
- reasons
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 1
- type
- Toxicity
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 2
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 3
- type
- Other
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 4
- type
- Withdrawal by Subject
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 32
- group Id
- FG001
- num Subjects
- 19
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 32
- group Id
- FG001
- num Subjects
- 19
- type
- NOT COMPLETED
- title
- Overall Study
- recruitment Details
- Patients were recruited in 10 centers in Spain and USA between June 2004 and June 2008.
Complete source fields
- groups
- description
- Plitidepsin 5 mg/m2 given as a 3-hour i.v. infusion every two weeks.
- id
- FG000
- title
- Plitidepsin
- description
- Plitidepsin 5 mg/m2 given as a 3-hour i.v. infusion every two weeks plus 20 mg of oral dexamethasone every day on days 1 to 4 of each cycle, starting at the same time than the plitidepsin infusion.
- id
- FG001
- title
- Plitidepsin + Dexamethasone
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 18
- group Id
- FG001
- num Subjects
- 9
- type
- Progressive disease
- reasons
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 1
- type
- Toxicity
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 2
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 3
- type
- Other
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 4
- type
- Withdrawal by Subject
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 32
- group Id
- FG001
- num Subjects
- 19
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 32
- group Id
- FG001
- num Subjects
- 19
- type
- NOT COMPLETED
- title
- Overall Study
- recruitment Details
- Patients were recruited in 10 centers in Spain and USA between June 2004 and June 2008.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle